COVID-19 in PID Survey

Launched by IMAGINE INSTITUTE · Jul 3, 2020

Keywords

ClinConnect Summary

The COVID-19 in PID Survey, also known as the COPID19 survey, is a study aimed at understanding how COVID-19 affects individuals with Primary Immune Deficiencies (PID). These are conditions where the immune system doesn’t work properly, making it harder for the body to fight infections. The researchers want to gather more information about how COVID-19 has impacted these patients, as previous studies have mostly focused on other health issues like diabetes or heart disease, leaving a gap in knowledge for those with PID.

To be eligible for this study, participants must have been diagnosed with a Primary Immune Deficiency and have either a confirmed or suspected case of COVID-19. The survey is open to people of all ages and genders. Participants will not have to do anything extra; healthcare professionals will enter data about their patients into a secure online platform. This information will help researchers gain a deeper understanding of the effects of COVID-19 on this vulnerable group, which is crucial for improving care and outcomes for individuals with primary immune deficiencies.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Diagnosed with a Primary Immune Deficiency
• • COVID-19 (proven or probable)
• Exclusion Criteria:
• • Secondary Immune Deficiency
• • Other Coronovirus infection